CRISPR Therapeutics AG

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC CRSP

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

148,901

Value ($000)

7,808

Weight

0.0%

2020 Q1 - 2025 Q4 (23 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	7,808	0.0%	148,901	12/31/2025
2025 Q2	8/14/2025	46,923	0.0%	964,690	6/30/2025
2025 Q1	5/19/2025	66,452	0.0%	1,952,751	3/31/2025
2024 Q4	2/14/2025	27,166	0.0%	690,191	12/31/2024
2024 Q3	11/14/2024	31,774	0.0%	676,326	9/30/2024
2024 Q2	8/14/2024	37,481	0.0%	693,958	6/30/2024
2024 Q1	5/15/2024	7,529	0.0%	110,465	3/31/2024
2023 Q4	2/14/2024	6,006	0.0%	95,950	12/31/2023
2023 Q3	11/13/2023	4,227	0.0%	93,125	9/30/2023
2023 Q2	8/11/2023	3,722	0.0%	82,286	6/30/2023
2023 Q1	5/15/2023	3,722	0.0%	82,286	3/31/2023
2022 Q4	2/14/2023	3,086	0.0%	75,906	12/31/2022
2022 Q3	11/14/2022	4,953	0.0%	75,786	9/30/2022
2022 Q2	8/12/2022	8,092	0.0%	133,154	6/30/2022
2022 Q1	5/16/2022	7,490	0.0%	119,327	3/31/2022
2021 Q4	2/14/2022	9,058	0.0%	119,533	12/31/2021
2021 Q3	11/15/2021	12,807	0.0%	114,420	9/30/2021
2021 Q2	8/16/2021	18,976	0.0%	117,213	6/30/2021
2021 Q1	5/14/2021	17,187	0.0%	141,054	3/31/2021
2020 Q4	3/1/2021	16,344	0.0%	106,746	12/31/2020
2020 Q3	11/13/2020	10,086	0.0%	120,592	9/30/2020
2020 Q2	8/14/2020	10,217	0.0%	139,030	6/30/2020
2020 Q1	5/15/2020	5,527	0.0%	130,328	3/31/2020